Tuberculosis chemoprophylaxis practices in metropolitan clinics

Area of Science:

• Public Health
• Infectious Disease Epidemiology
• Preventive Medicine

Background:

• Tuberculosis (TB) remains a significant public health concern, necessitating effective chemoprophylaxis strategies.
• Standardized guidelines for TB preventive therapy are crucial for consistent patient care and disease control.
• Understanding current practices in large metropolitan programs is essential for evaluating guideline adherence.

Purpose of the Study:

• To survey tuberculosis chemoprophylaxis policies in major US metropolitan programs.
• To assess adherence to established guidelines from the American Thoracic Society and the US Public Health Service.
• To identify variations in preventive therapy practices among these programs.

Main Methods:

• A survey was conducted from September 1977 to January 1978.
• All 28 metropolitan programs reporting over 100 tuberculosis cases in 1976 were included.
• Data collected focused on isoniazid dosage, treatment duration, indications, and specific practices like use in pregnant women and medication dispensing.

Main Results:

• High uniformity was observed in isoniazid dosage, treatment duration, and general indications for preventive therapy.
• One-third of programs provided chemoprophylaxis to pregnant women, and one-third dispensed more than a one-month supply of isoniazid.
• Hepatitis function monitoring was infrequent (11%), and Bacillus Calmette-Guérin (BCG) vaccine use was limited (14%).

Conclusions:

• Large metropolitan tuberculosis programs largely adhered to national guidelines for chemoprophylaxis.
• Notable variances in specific practices, including management of pregnant women and medication dispensing, were identified.
• Further evaluation is needed to understand the rationale behind and impact of these practice variations.